Novartis traded at $85.47 this Monday February 6th, decreasing $0.38 or 0.44 percent since the previous trading session. Looking back, over the last four weeks, Novartis lost 4.98 percent. Over the last 12 months, its price fell by 2.00 percent. Looking ahead, we forecast Novartis to be priced at 83.51 by the end of this quarter and at 76.88 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 145.02 -0.18 -0.12% 1.75%
Amgen 243.85 -1.32 -0.54% 9.09%
AstraZeneca 10,592.00 12.00 0.11% 27.86%
AstraZeneca 63.52 0.08 0.13% 12.07%
Biogen 288.28 4.65 1.64% 30.27%
Bristol-Myers Squibb 74.53 0.08 0.11% 12.60%
Corcept Therapeutics 23.96 -0.36 -1.48% 21.69%
Catalent 67.00 10.95 19.54% -35.06%
Endo International 0.09 -0.003 -2.82% -97.03%
Gilead Sciences 86.36 1.86 2.20% 35.57%
GlaxoSmithKline 1,485.20 24.20 1.66% -9.65%
Glaxosmithkline 35.34 0.51 1.46% -21.45%
Horizon Pharma 110.25 0.57 0.52% 17.57%
Jazz Pharmaceuticals 153.13 -2.51 -1.61% 8.50%
J&J 163.36 -1.25 -0.76% -4.50%
Lannett 2.59 -0.10 -3.83% 186.90%
Eli Lilly 337.66 -1.42 -0.42% 38.64%
Merck & Co 104.03 1.09 1.06% 35.26%
Phibro Animal Health 15.99 -0.27 -1.66% -14.63%
Prestige Brands 60.82 -0.14 -0.23% 6.12%
Pacira 41.24 -0.62 -1.48% -34.86%
Pfizer 43.76 -0.30 -0.68% -17.76%
Powershares High Yield Orate Bond Portfolio 17.51 -0.12 -0.68% -6.41%
Perrigo 36.29 -0.91 -2.45% -1.79%
Drreddys Laboratories 52.96 -0.13 -0.24% -7.93%
Roche Holding 283.90 0 0% -17.92%
Sanofi 86.51 1.60 1.88% -7.68%
Sanofi 45.86 -0.16 -0.35% -13.55%
Supernus Pharmaceuticals 40.75 -0.86 -2.07% 30.65%
Teva Pharmaceutical Industries 10.73 -0.03 -0.28% 26.83%
United States Oil Fund 65.50 1.10 1.71% 1.27%
Bausch Health Companies Inc 10.31 -0.22 -2.09% -66.65%
Canopy Growth Corp 3.94 0.01 0.25% -60.32%
Zoetis 164.93 -2.87 -1.71% -17.67%


Novartis
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.